CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Neumora Therapeutics Plans Q4 IND Filing for Obesity Drug After Repeat Toxicology Study

Positive
AI Analysis

Summary

Neumora Therapeutics plans to file an IND application in Q4 2026 for an obesity drug candidate after completing a repeat toxicology study.

Importance:5/10
Sentiment:
0.50
obesityIND filingpreclinicaltoxicology
Related Companies

Read the original article

Published by yahoo_finance on July 27, 2026 12:21 PM

Read Original